Gene-based aggregate SNP associations between candidate AD genes and cognitive decline

Age

Volumn 38, Issue 2, 2016, Pages

  Nettiksimmons, Jasmine ^a   Tranah, Gregory ^b   Evans, Daniel S ^c   Yokoyama, Jennifer S ^d   Yaffe, Kristine ^d  

^a UNIVERSITY OF SAN FRANCISCO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Candidate AD genes; Cognitive decline; SNP associations

Indexed keywords

ABCA7 GENE; ADULT; AGE DISTRIBUTION; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; BIN1 GENE; CASS4 GENE; CD2AP GENE; CD33 GENE; CELF1 GENE; CLU GENE; COGNITION ASSESSMENT; COGNITIVE DEFECT; COMMUNITY LIVING; EPHA1 GENE; EXOC3L2 GENE; FEMALE; FERMT2 GENE; GENE; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC VARIABILITY; HLA DQA GENE; HLA DRB5 GENE; HUMAN; INPP5D GENE; MALE; MEF2C GENE; MS4A3 GENE; MS4A6E GENE; NME8 GENE; PICALM GENE; POPULATION DISTRIBUTION; PROMOTER REGION; PTK2B GENE; QUANTITATIVE TRAIT LOCUS; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SLC24A4 GENE; SORL1 GENE; COGNITION DISORDERS; COMPLICATION; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; METABOLISM; PROCEDURES;

DNA;

AGED; AGING; ALZHEIMER DISEASE; COGNITION DISORDERS; DNA; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84961629632     PISSN: 01619152     EISSN: 15744647     Source Type: Journal    
DOI: 10.1007/s11357-016-9885-2     Document Type: Article

References (33)

1. Barker WW, Luis CA, Kashuba A, Luis M, Harwood DG, Loewenstein D, … Duara R (2002) Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank. Alzheimer Dis Assoc Disord 16(4): 203–212.
2. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 57:289–300
3. Blank JB, Cawthon PM, Carrion-Petersen ML, Harper L, Johnson JP, Mitson E, Delay RR (2005) Overview of recruitment for the osteoporotic fractures in men study (MrOS). Contemp Clin Trials 26(5):557–568. doi:10.1016/j.cct.2005.05.005
4. Bradshaw EM, Chibnik LB, Keenan BT, Ottoboni L, Raj T, Tang A, … De Jager PL (2013) CD33 Alzheimer’s disease locus: altered monocyte function and amyloid biology. Nat Neurosci 16(7):848–850. doi:10.1038/nn.3435
5. Cargill R, Kohama SG, Struve J, Su W, Banine F, Witkowski E, … Sherman LS (2012) Astrocytes in aged nonhuman primate brain gray matter synthesize excess hyaluronan. Neurobiol Aging 33(4):830. e813–824. doi:10.1016/j.neurobiolaging.2011.07.006
6. Crehan H, Holton P, Wray S, Pocock J, Guerreiro R, Hardy J (2012) Complement receptor 1 (CR1) and Alzheimer’s disease. Immunobiology 217(2):244–250. doi:10.1016/j.imbio.2011.07.017
7. Crocker PR, McMillan SJ, Richards HE (2012) CD33-related siglecs as potential modulators of inflammatory responses. Ann N Y Acad Sci 1253:102–111. doi:10.1111/j.1749-6632.2011.06449.x
8. Crocker PR, Paulson JC, Varki A (2007) Siglecs and their roles in the immune system. Nat Rev Immunol 7(4):255–266. doi:10.1038/nri2056
9. Cummings SR, Black DM, Nevitt MC, Browner WS, Cauley JA, Genant HK et al (1990) Appendicular bone density and age predict hip fracture in women. The Study of Osteoporotic Fractures Research Group. JAMA 263(5):665–668
10. Dasgupta T, Ladd AN (2012) The importance of CELF control: molecular and biological roles of the CUG-BP, Elav-like family of RNA-binding proteins. Wiley Interdiscip Rev RNA 3(1):104–121. doi:10.1002/wrna.107
11. Ebbert MT, Ridge PG, Wilson AR, Sharp AR, Bailey M, Norton MC, …. Kauwe JS (2014) Population-based analysis of Alzheimer’s disease risk alleles implicates genetic interactions. Biol Psychiatry 75(9):732–737. doi: 10.1016/j.biopsych.2013.07.008
12. Gould R, Abramson I, Galasko D, Salmon D (2001) Rate of cognitive change in Alzheimer’s disease: methodological approaches using random effects models. J Int Neuropsychol Soc 7(7):813–824
13. Griciuc A, Serrano-Pozo A, Parrado AR, Lesinski AN, Asselin CN, Mullin K, … Tanzi RE (2013) Alzheimer’s disease risk gene CD33 inhibits microglial uptake of amyloid beta. Neuron 78(4):631–643. doi: 10.1016/j.neuron.2013.04.014
14. Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML,…. Williams J (2009) Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer’s disease. Nat Genet 41(10):1088–1093. doi: 10.1038/ng.440
15. Harris SE, Davies G, Luciano M, Payton A, Fox HC, Haggarty P, … Deary IJ (2014) Polygenic risk for Alzheimer’s disease is not associated with cognitive ability or cognitive aging in non-demented older people. J Alzheimers Dis 39(3):565–574. doi: 10.3233/JAD-131058
16. Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, Carrasquillo MM, … Williams J (2011) Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease. Nat Genet 43(5):429–435. doi: 10.1038/ng.803
17. Howie B, Fuchsberger C, Stephens M, Marchini J, Abecasis GR (2012) Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat Genet 44(8):955–959. doi:10.1038/ng.2354
18. Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, …. Amouyel P (2013) Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nat Genet 45(12):1452–1458. doi: 10.1038/ng.2802
19. Li Y, Abecasis GR (2006) Mach 1.0: rapid haplotype reconstruction and missing genotype inference. Am J Hum Genet S 79(3):2290
20. Malik M, Simpson JF, Parikh I, Wilfred BR, Fardo DW, Nelson PT, Estus S (2013) CD33 Alzheimer’s risk-altering polymorphism, CD33 expression, and exon 2 splicing. J Neurosci 33(33):13320–13325. doi:10.1523/JNEUROSCI.1224-13.2013
21. Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, Buros J, … Schellenberg GD (2011) Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer’s disease. Nat Genet 43(5):436–441. doi: 10.1038/ng.801
22. Orwoll E, Blank JB, Barrett-Connor E, Cauley J, Cummings S, Ensrud K, … Stone K (2005) Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study—a large observational study of the determinants of fracture in older men. Contemp Clin Trials 26(5):569–585. doi: 10.1016/j.cct.2005.05.006
23. Pillai S, Netravali IA, Cariappa A, Mattoo H (2012) Siglecs and immune regulation. Annu Rev Immunol 30:357–392. doi:10.1146/annurev-immunol-020711-075018
24. Pruim R, Welch R, Sanna S, Teslovich T, Chines P, Gliedt T, … Willer C (2010) LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics (Oxford, England) 26(18):2336–2337.
25. Ramasamy A, Trabzuni D, Guelfi S, Varghese V, Smith C, Walker R, … Weale ME (2014) Genetic variability in the regulation of gene expression in ten regions of the human brain. Nat Neurosci 17(10):1418–1428. doi: 10.1038/nn.3801
26. Schork NJ, Murray SS, Frazer K a, Topol EJ (2009) Common vs. rare allele hypotheses for complex diseases. Curr Opin Genet Dev 19:212–219. doi:10.1016/j.gde.2009.04.010
27. Seshadri S, Fitzpatrick AL, Ikram MA, DeStefano AL, Gudnason V, Boada M, …. Consortium E (2010) Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA 303(18):1832–1840. doi: 10.1001/jama.2010.574
28. Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM, Sirotkin K (2001) dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 29(1):308–311
29. Torkamani A, Topol EJ, Schork NJ (2008) Pathway analysis of seven common diseases assessed by genome-wide association. Genomics 92(5):265–272. doi:10.1016/j.ygeno.2008.07.011
30. Verhaaren BF, Vernooij MW, Koudstaal PJ, Uitterlinden AG, van Duijn CM, Hofman A, … Ikram MA (2013) Alzheimer’s disease genes and cognition in the nondemented general population. Biol Psychiatry 73(5):429–434. doi: 10.1016/j.biopsych.2012.04.009
31. von Gunten S, Bochner BS (2008) Basic and clinical immunology of Siglecs. Ann N Y Acad Sci 1143:61–82. doi:10.1196/annals.1443.011
32. Wu MC, Kraft P, Epstein MP, Taylor DM, Chanock SJ, Hunter DJ, Lin X (2010) Powerful SNP-set analysis for case–control genome-wide association studies. Am J Hum Genet 86(6):929–942. doi:10.1016/j.ajhg.2010.05.002
33. Wu MC, Lee S, Cai T, Li Y, Boehnke M, Lin X (2011) Rare-variant association testing for sequencing data with the sequence kernel association test. Am J Hum Genet 89(1):82–93. doi:10.1016/j.ajhg.2011.05.029